Abstract
There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis and the risk of bleeding. The full consensus document comprehensively reviews the published evidence and presents a consensus statement on a 'best practice' antithrombotic therapy guideline for the management of antithrombotic therapy in such AF patients. This executive summary highlights the main recommendations from the consensus document.
Original language | English |
---|---|
Pages (from-to) | 1311-U12 |
Journal | European Heart Journal |
Volume | 31 |
Issue number | 11 |
DOIs | |
Publication status | Published - 1 Jun 2010 |
Keywords
- Stenting
- Acute coronary syndrome
- Antithrombotic therapy
- Warfarin
- Atrial fibrillation
- Percutaneous coronary intervention